Efficacy and Tolerability of Xalatan in Patients (A6111128)

Viatris

Status: Completed

Conditions: Glaucoma; Ocular Hypertension

Treatments: Drug: Xalatan 0.005% eye drops

Study type: Observational

Funder types: Industry

Identifiers

NCT00950690

A6111128

Details and patient eligibility

About

Efficacy data was not collected or analyzed. This study did assess safety and tolerability of Xalatan.

Full description

• Efficacy data not collected or analyzed
• Safety and tolerability of Xalatan assessed NA

Enrollment: 1,289 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with ocular hypertension at least 22mg Hg
• Patient must be over 18 years old

Exclusion criteria

• None listed in the protocol

Trial design

1,289 participants in 1 patient group

Study Drug - Xalatan 0.005% eye drops

Treatment:

Drug: Xalatan 0.005% eye drops